These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9286612)

  • 1. Effects of AMPA receptor positive modulators on amphetamine- and dizocilpine-induced locomotion.
    Vanover KE
    Eur J Pharmacol; 1997 Aug; 332(2):115-9. PubMed ID: 9286612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice.
    Vanover KE
    Psychopharmacology (Berl); 1998 Mar; 136(2):123-31. PubMed ID: 9551768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice.
    O'Neill MF; Shaw G
    Psychopharmacology (Berl); 1999 Aug; 145(3):237-50. PubMed ID: 10494572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interactions between ampakines and antipsychotic drugs.
    Johnson SA; Luu NT; Herbst TA; Knapp R; Lutz D; Arai A; Rogers GA; Lynch G
    J Pharmacol Exp Ther; 1999 Apr; 289(1):392-7. PubMed ID: 10087029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
    Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
    J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    Leite JV; Guimarães FS; Moreira FA
    Eur J Pharmacol; 2008 Jan; 578(2-3):222-7. PubMed ID: 18021764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MK-801 and amphetamine result in dissociable profiles of cognitive impairment in a rodent paired associates learning task with relevance for schizophrenia.
    Talpos J; Aerts N; Waddell J; Steckler T
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3911-20. PubMed ID: 25902874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR; Vanover KE; Pounds L; Johnson RW; Barido R; Anderson GT; Veinbergs I; Dyssegaard A; Brunmark P; Tabatabaei A; Davis RE; Brann MR; Hacksell U; Bonhaus DW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):862-70. PubMed ID: 17519387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
    O'Neill MF; Heron-Maxwell C; Conway MW; Monn JA; Ornstein P
    Neuropharmacology; 2003 Oct; 45(5):565-74. PubMed ID: 12941370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnarizine has an atypical antipsychotic profile in animal models of psychosis.
    Dall'Igna OP; Tort AB; Souza DO; Lara DR
    J Psychopharmacol; 2005 Jul; 19(4):342-6. PubMed ID: 15982988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dissociable mechanisms of amphetamine- and stress-induced behavioral sensitization: effects of MK-801 and haloperidol pretreatment.
    Tolliver BK; Ho LB; Reid MS; Berger SP
    Psychopharmacology (Berl); 1996 Aug; 126(3):191-8. PubMed ID: 8876018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine.
    Gaiardi M; Gubellini C; Dall'Olio R; Gandolfi O; Bartoletti M
    Behav Pharmacol; 2001 Sep; 12(5):317-24. PubMed ID: 11710746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of the GYKI 53784-induced inhibition of AMPA currents by various AMPA-positive modulators in cerebellar Purkinje cells.
    Kapus G; Bódi I; Pataki A; Gueritaud J; Székely JI; Tarnawa I
    Eur J Pharmacol; 2000 May; 397(1):43-7. PubMed ID: 10844097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2 receptors modulate the expression of antipsychotic-induced dopamine supersensitivity.
    Charron A; Hage CE; Servonnet A; Samaha AN
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2381-93. PubMed ID: 26508706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
    de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
    Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-dependent blockade of haloperidol-induced sensitization of catalepsy by MK-801.
    Schmidt WJ; Tzschentke TM; Kretschmer BD
    Eur J Neurosci; 1999 Sep; 11(9):3365-8. PubMed ID: 10510204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
    O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.